Childhood Cancer

You are here

Acute Myeloid Leukemia (AML)

Childhood acute myeloid leukemia (AML) is a cancer of the myeloid cells that form white blood cells, red blood cells or platelets. AML is the second most common form of childhood leukemia. View the 2023 Impact Report.

Latest Acute Myeloid Leukemia (AML) grants

Dirk Loeffler, PhD, Principal Investigator
St. Jude Children’s Research Hospital
RUNX1 Early Career Investigator Grants, Awarded 2023
Brittany Stewart, PhD, Principal Investigator
The Cleveland Clinic Foundation
RUNX1 Early Career Investigator Grants, Awarded 2023
Muxiang Zhou, MD, Principal Investigator
Emory University
Reach Grants, Awarded 2023

Latest Acute Myeloid Leukemia (AML) blog posts

Kids come in all shapes and sizes, and so do their cancers. There are dozens of pediatric cancers, but leukemia accounts for nearly 28% of all childhood cancer diagnoses. Leukemia is a cancer of the white blood cells – which are crucial to... more
As the Alex’s Lemonade Stand Foundation (ALSF) Director of Science, I work to evaluate our funded research projects to track progress and find gaps in funding so that we can direct more research dollars to the largest areas of need, and to... more
When Lilly faced surgery after relapsing, her family made the decision to donate extra tumor tissue to research instead of throwing it away. 

“We hope that Lilly’s neuroblastoma tumor can be some small part of helping other children who... more